Administration of non-pathogenic isolates of Escherichia coli and Clostridium perfringens type A to piglets in a herd affected with a high incidence of neonatal diarrhoea

A bacterial cocktail of living strains of Clostridium perfringens type A (CPA) without β2-toxin gene and non-pathogenic Escherichia coli was administered orally to newborn piglets before first colostrum intake and on 2 consecutive days on a farm with a high incidence of diarrhoea and antibiotic trea...

Full description

Bibliographic Details
Main Authors: C. Unterweger, A. Kahler, G.-F. Gerlach, M. Viehmann, A. von Altrock, I. Hennig-Pauka
Format: Article
Language:English
Published: Elsevier 2017-01-01
Series:Animal
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S1751731116001804
id doaj-f81d8747acd24f80a4a5e5e11ae9fc25
record_format Article
spelling doaj-f81d8747acd24f80a4a5e5e11ae9fc252021-06-06T04:52:42ZengElsevierAnimal1751-73112017-01-01114670676Administration of non-pathogenic isolates of Escherichia coli and Clostridium perfringens type A to piglets in a herd affected with a high incidence of neonatal diarrhoeaC. Unterweger0A. Kahler1G.-F. Gerlach2M. Viehmann3A. von Altrock4I. Hennig-Pauka5University Clinic for Swine, University of Veterinary Medicine, Veterinaerplatz 1, 1210 Vienna, AustriaUniversity Clinic for Swine, University of Veterinary Medicine, Veterinaerplatz 1, 1210 Vienna, AustriaInnovative Veterinary Diagnostic GmbH, Heisterbergallee 12, 30453 Hannover, GermanyUniversity Clinic for Swine, University of Veterinary Medicine, Veterinaerplatz 1, 1210 Vienna, AustriaClinic for Swine, Small Ruminants, Forensic Medicine and Ambulatory Service, University of Veterinary Medicine Hannover, Foundation, Bischofsholer Damm 15, 30173 Hannover, GermanyUniversity Clinic for Swine, University of Veterinary Medicine, Veterinaerplatz 1, 1210 Vienna, AustriaA bacterial cocktail of living strains of Clostridium perfringens type A (CPA) without β2-toxin gene and non-pathogenic Escherichia coli was administered orally to newborn piglets before first colostrum intake and on 2 consecutive days on a farm with a high incidence of diarrhoea and antibiotic treatment in suckling piglets associated with E. coli and CPA. This clinical field study was driven by the hypothetic principle of competitive exclusion of pathogenic bacteria due to prior colonization of the gut mucosal surface by non-pathogenic strains of the same bacterial species with the aim of preventing disease. Although CPA strains used in this study did not produce toxins in vitro, their lack of pathogenicity cannot be conclusively confirmed. The health status of the herd was impaired by a high incidence of postpartum dysgalactia syndrome in sows (70%) and a high incidence of neonatal diarrhoea caused by enterotoxigenic E. coli and CPA during the study. No obvious adverse effect of the bacterial treatment occurred. On average, more piglets were weaned in litters treated (P=0.009). Visual pathological alterations in the small intestinal wall were more frequent in dead piglets of the control group (P=0.004) and necrotizing enteritis was only found in that group. A higher average daily weight gain of piglets in the control group (P<0.001) may be due to an increased milk uptake due to less competition in the smaller litters. The bacterial cocktail was tested under field conditions for its potential to stabilize gut health status in suckling piglets before disease development due to colibacillosis and clostridial infections; however, the gut flora stabilizing effect of the bacterial cocktail was not clearly discernible in this study. Further basic research is needed to confirm the positive effects of the bacterial treatment used and to identify additional potential bacterial candidates for competitive exclusion.http://www.sciencedirect.com/science/article/pii/S1751731116001804probioticsEscherichia coliClostridium perfringensprotection by competitionfield trial
collection DOAJ
language English
format Article
sources DOAJ
author C. Unterweger
A. Kahler
G.-F. Gerlach
M. Viehmann
A. von Altrock
I. Hennig-Pauka
spellingShingle C. Unterweger
A. Kahler
G.-F. Gerlach
M. Viehmann
A. von Altrock
I. Hennig-Pauka
Administration of non-pathogenic isolates of Escherichia coli and Clostridium perfringens type A to piglets in a herd affected with a high incidence of neonatal diarrhoea
Animal
probiotics
Escherichia coli
Clostridium perfringens
protection by competition
field trial
author_facet C. Unterweger
A. Kahler
G.-F. Gerlach
M. Viehmann
A. von Altrock
I. Hennig-Pauka
author_sort C. Unterweger
title Administration of non-pathogenic isolates of Escherichia coli and Clostridium perfringens type A to piglets in a herd affected with a high incidence of neonatal diarrhoea
title_short Administration of non-pathogenic isolates of Escherichia coli and Clostridium perfringens type A to piglets in a herd affected with a high incidence of neonatal diarrhoea
title_full Administration of non-pathogenic isolates of Escherichia coli and Clostridium perfringens type A to piglets in a herd affected with a high incidence of neonatal diarrhoea
title_fullStr Administration of non-pathogenic isolates of Escherichia coli and Clostridium perfringens type A to piglets in a herd affected with a high incidence of neonatal diarrhoea
title_full_unstemmed Administration of non-pathogenic isolates of Escherichia coli and Clostridium perfringens type A to piglets in a herd affected with a high incidence of neonatal diarrhoea
title_sort administration of non-pathogenic isolates of escherichia coli and clostridium perfringens type a to piglets in a herd affected with a high incidence of neonatal diarrhoea
publisher Elsevier
series Animal
issn 1751-7311
publishDate 2017-01-01
description A bacterial cocktail of living strains of Clostridium perfringens type A (CPA) without β2-toxin gene and non-pathogenic Escherichia coli was administered orally to newborn piglets before first colostrum intake and on 2 consecutive days on a farm with a high incidence of diarrhoea and antibiotic treatment in suckling piglets associated with E. coli and CPA. This clinical field study was driven by the hypothetic principle of competitive exclusion of pathogenic bacteria due to prior colonization of the gut mucosal surface by non-pathogenic strains of the same bacterial species with the aim of preventing disease. Although CPA strains used in this study did not produce toxins in vitro, their lack of pathogenicity cannot be conclusively confirmed. The health status of the herd was impaired by a high incidence of postpartum dysgalactia syndrome in sows (70%) and a high incidence of neonatal diarrhoea caused by enterotoxigenic E. coli and CPA during the study. No obvious adverse effect of the bacterial treatment occurred. On average, more piglets were weaned in litters treated (P=0.009). Visual pathological alterations in the small intestinal wall were more frequent in dead piglets of the control group (P=0.004) and necrotizing enteritis was only found in that group. A higher average daily weight gain of piglets in the control group (P<0.001) may be due to an increased milk uptake due to less competition in the smaller litters. The bacterial cocktail was tested under field conditions for its potential to stabilize gut health status in suckling piglets before disease development due to colibacillosis and clostridial infections; however, the gut flora stabilizing effect of the bacterial cocktail was not clearly discernible in this study. Further basic research is needed to confirm the positive effects of the bacterial treatment used and to identify additional potential bacterial candidates for competitive exclusion.
topic probiotics
Escherichia coli
Clostridium perfringens
protection by competition
field trial
url http://www.sciencedirect.com/science/article/pii/S1751731116001804
work_keys_str_mv AT cunterweger administrationofnonpathogenicisolatesofescherichiacoliandclostridiumperfringenstypeatopigletsinaherdaffectedwithahighincidenceofneonataldiarrhoea
AT akahler administrationofnonpathogenicisolatesofescherichiacoliandclostridiumperfringenstypeatopigletsinaherdaffectedwithahighincidenceofneonataldiarrhoea
AT gfgerlach administrationofnonpathogenicisolatesofescherichiacoliandclostridiumperfringenstypeatopigletsinaherdaffectedwithahighincidenceofneonataldiarrhoea
AT mviehmann administrationofnonpathogenicisolatesofescherichiacoliandclostridiumperfringenstypeatopigletsinaherdaffectedwithahighincidenceofneonataldiarrhoea
AT avonaltrock administrationofnonpathogenicisolatesofescherichiacoliandclostridiumperfringenstypeatopigletsinaherdaffectedwithahighincidenceofneonataldiarrhoea
AT ihennigpauka administrationofnonpathogenicisolatesofescherichiacoliandclostridiumperfringenstypeatopigletsinaherdaffectedwithahighincidenceofneonataldiarrhoea
_version_ 1721395034740228096